Last 48 quarters of trend data · Healthcare · Medical Supplies & Consumables
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 71.73 | 37.50 | 48.22 | 26.91 | — | — | 23.10 | — | — | — | — | — | — | 99.18 | — | — | — | — | — | — | 65.20 |
| — | — | +108.7% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +47.1% | |
| P/S Ratio | 1.97 | 1.80 | 1.66 | 1.53 | 1.63 | 1.38 | 1.49 | 1.41 | 1.51 | 1.89 | 1.21 | 1.15 | 1.02 | 1.31 | 1.95 | 1.74 | 1.63 | 1.51 | 1.75 | 2.42 | 3.80 |
| — | +30.6% | +11.9% | +8.8% | +8.0% | -27.0% | +22.5% | +22.8% | +47.3% | +44.2% | -37.8% | -34.1% | -37.3% | -13.0% | +11.5% | -28.1% | -57.0% | -60.1% | -49.6% | -30.8% | +5.1% | |
| P/B Ratio | 2.02 | 1.84 | 1.71 | 1.54 | 1.66 | 1.39 | 1.54 | 1.71 | 1.93 | 2.17 | 1.42 | 1.26 | 1.13 | 1.38 | 2.03 | 1.89 | 1.81 | 1.79 | 1.88 | 2.42 | 3.20 |
| — | +32.3% | +10.6% | -10.2% | -14.2% | -36.0% | +8.6% | +36.4% | +70.5% | +57.3% | -29.9% | -33.3% | -37.3% | -22.7% | +7.7% | -21.9% | -43.6% | -43.9% | -34.3% | -17.6% | +3.8% | |
| P/FCF | 20.62 | 12.10 | 14.89 | 29.45 | 24.49 | 26.79 | — | 23.21 | 69.89 | 51.66 | 11.59 | 24.14 | 10.15 | 68.38 | — | 36.62 | — | — | — | — | 18.29 |
| — | -54.8% | — | +26.9% | -65.0% | -48.1% | — | -3.9% | +588.5% | -24.5% | — | -34.1% | — | — | — | — | — | — | — | — | -26.1% | |
| EV / EBITDA | 15.35 | 11.99 | 13.09 | 13.34 | 14.47 | 15.60 | 18.07 | 18.92 | 14.15 | 22.69 | 16.95 | 22.48 | 21.45 | 3.72 | 24.13 | 21.02 | 23.43 | 21.89 | 20.37 | 152.32 | 24.85 |
| — | -23.2% | -27.6% | -29.5% | +2.3% | -31.2% | +6.6% | -15.8% | -34.0% | +509.2% | -29.7% | +6.9% | -8.5% | -83.0% | +18.5% | -86.2% | -5.7% | +15.5% | +13.8% | +626.9% | +18.0% | |
| EV / EBIT | 50.36 | 22.50 | 27.85 | — | 178.57 | 63.89 | 19.19 | 82.16 | 37.30 | 154.92 | 150.15 | — | — | 94.06 | 489.67 | 125.81 | — | — | — | — | 49.23 |
| — | -64.8% | +45.1% | — | +378.7% | -58.8% | -87.2% | — | — | +64.7% | -69.3% | — | — | — | — | — | — | — | — | — | +38.9% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.8% | 41.9% | 42.6% | 32.6% | 37.4% | 37.4% | 37.9% | 34.7% | 36.1% | 34.8% | 34.8% | 32.7% | 29.2% | 33.2% | 35.0% | 33.8% | 30.3% | 31.2% | 29.9% | 31.1% | 37.4% |
| — | +12.0% | +12.4% | -6.1% | +3.7% | +7.6% | +9.0% | +6.3% | +23.6% | +4.6% | -0.7% | -3.2% | -3.6% | +6.6% | +17.2% | +8.6% | -19.2% | -18.0% | -22.2% | -12.3% | +0.1% | |
| Operating Margin | 4.8% | 9.3% | 7.1% | 5.8% | 4.7% | 2.6% | 1.9% | 2.1% | 6.0% | 1.4% | 1.3% | -1.9% | -2.1% | 4.1% | 0.5% | 1.7% | -0.0% | -0.1% | -0.0% | -7.8% | 7.0% |
| — | +265.4% | +267.7% | +171.4% | -22.0% | +82.7% | +49.6% | +213.3% | +388.8% | -66.2% | +156.7% | -213.8% | -5296.9% | +5388.3% | +5941.9% | +121.3% | -100.5% | -100.7% | -100.1% | -192.9% | -17.0% | |
| Net Margin | 0.0% | 4.8% | 3.5% | 5.7% | -2.9% | -0.6% | 6.4% | -2.6% | -3.8% | -5.6% | -3.6% | -7.0% | -2.9% | 1.3% | -1.8% | -1.7% | -2.7% | -2.2% | -1.3% | -7.0% | 5.9% |
| — | +857.5% | -46.3% | +322.0% | +23.0% | +88.7% | +279.4% | +63.3% | -29.7% | -528.0% | -98.4% | -303.7% | -8.5% | +159.2% | -35.7% | +75.4% | -145.9% | -123.9% | -115.1% | -193.9% | -28.3% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.0% | 1.2% | 0.9% | 1.4% | -0.7% | -0.2% | 1.7% | -0.8% | -1.2% | -1.6% | -1.0% | -1.9% | -0.8% | 0.3% | -0.5% | -0.5% | -0.8% | -0.6% | -0.4% | -2.0% | 1.2% |
| — | +872.2% | -48.0% | +281.7% | +37.7% | +90.1% | +265.2% | +58.4% | -46.2% | -569.8% | -121.3% | -302.2% | -7.3% | +153.3% | -34.5% | +76.7% | -160.9% | -132.6% | -119.0% | -227.8% | -29.8% | |
| ROA | 0.0% | 0.7% | 0.5% | 0.7% | -0.4% | -0.1% | 0.9% | -0.4% | -0.6% | -0.8% | -0.5% | -0.9% | -0.4% | 0.2% | -0.2% | -0.2% | -0.3% | -0.3% | -0.2% | -1.1% | 1.1% |
| — | +920.3% | -43.9% | +302.5% | +31.1% | +89.2% | +270.7% | +59.5% | -43.0% | -568.7% | -124.5% | -317.1% | -13.0% | +156.1% | -38.9% | +81.0% | -132.3% | -117.1% | -110.1% | -185.4% | -28.4% | |
| ROIC | 2.5% | 1.3% | 0.9% | 0.7% | 0.6% | 0.3% | 0.2% | 0.3% | 0.8% | 0.2% | 0.2% | -0.2% | -0.3% | 0.5% | 0.1% | 0.2% | -0.0% | -0.0% | -0.0% | -1.3% | 1.6% |
| — | +295.7% | +282.1% | +146.4% | -30.0% | +77.3% | +46.4% | +229.8% | +432.3% | -61.6% | +192.1% | -215.8% | -5308.5% | +4870.7% | +5810.0% | +114.5% | -100.3% | -100.4% | -100.0% | -177.7% | -8.3% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.66 | 0.53 | 0.59 | 0.64 | 0.66 | 0.64 | 0.66 | 0.81 | 0.84 | 0.81 | 0.82 | 0.82 | 0.80 | 0.82 | 0.81 | 0.83 | 0.83 | 0.86 | 0.84 | 0.80 | 0.03 |
| — | -18.1% | -10.1% | -21.1% | -21.5% | -20.8% | -20.3% | -1.3% | +4.1% | -0.9% | +1.1% | -1.1% | -3.3% | -5.4% | -2.6% | +2.6% | +2877.0% | +2828.0% | +2539.1% | +2281.3% | -20.5% | |
| Debt / EBITDA | 4.52 | 11.30 | 14.33 | 16.62 | 17.50 | 21.15 | 23.07 | 25.68 | 18.10 | 25.96 | 26.65 | 37.60 | 37.90 | 5.78 | 28.60 | 26.63 | 30.65 | 29.88 | 26.25 | 159.68 | 0.96 |
| — | -46.6% | -37.9% | -35.3% | -3.3% | -18.5% | -13.4% | -31.7% | -52.2% | +348.9% | -6.8% | +41.2% | +23.7% | -80.6% | +8.9% | -83.3% | +3094.7% | +3762.8% | +2910.0% | +15044.5% | -7.2% | |
| Current Ratio | 2.36 | 2.37 | 2.43 | 2.30 | 2.36 | 2.45 | 2.44 | 2.59 | 2.59 | 2.29 | 2.41 | 2.61 | 2.53 | 2.62 | 2.56 | 2.62 | 2.50 | 2.44 | 2.43 | 2.36 | 5.13 |
| — | -3.2% | -0.6% | -11.5% | -9.0% | +7.0% | +1.2% | -0.6% | +2.4% | -12.5% | -5.7% | -0.3% | +1.3% | +7.0% | +5.2% | +11.1% | -51.3% | -55.0% | -53.9% | -54.0% | +9.7% | |
| Quick Ratio | 1.13 | 1.19 | 1.21 | 1.13 | 1.13 | 1.19 | 1.17 | 1.52 | 1.54 | 1.03 | 1.08 | 1.09 | 1.06 | 0.98 | 0.96 | 1.00 | 1.09 | 1.17 | 1.23 | 1.27 | 3.68 |
| — | +0.3% | +3.7% | -25.8% | -27.0% | +15.2% | +8.1% | +39.8% | +45.6% | +5.2% | +12.9% | +8.8% | -2.9% | -16.1% | -22.4% | -21.4% | -70.4% | -69.8% | -66.2% | -63.2% | +20.1% | |
| Interest Coverage | 1.03 | 3.00 | 2.25 | -1.07 | 0.26 | 0.80 | 2.46 | 0.49 | 1.31 | 0.34 | 0.27 | -0.39 | -0.37 | 0.45 | 0.11 | 0.45 | -0.09 | -0.01 | -0.04 | -3.02 | 64.76 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ICUI stock.
ICU Medical, Inc.'s current P/E is 71.7x. The average P/E over the last 3 quarters is 37.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
ICU Medical, Inc.'s current operating margin is 4.8%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking ICU Medical, Inc.'s business trajectory between earnings reports.